181 related articles for article (PubMed ID: 4867598)
1. Treating psychical disturbances induced by physical disorders: a double-blind study of perphenazine-amitriptyline in anxiety and depression.
Davis WG
Psychosomatics; 1968; 9(1):44-6. PubMed ID: 4867598
[No Abstract] [Full Text] [Related]
2. Emotion and skin--a double blind evaluation of psychotropic agents.
Medansky RS
Psychosomatics; 1971; 12(5):326-9. PubMed ID: 4950857
[No Abstract] [Full Text] [Related]
3. Psychogenic headaches with mixed anxiety and depression.
Diamond S
IMJ Ill Med J; 1975 Mar; 147(3):268-9. PubMed ID: 236227
[No Abstract] [Full Text] [Related]
4. Treatment of anxiety and depression. A double-blind study of a perphenazine and amitriptyline in combination.
Davis WG
Rocky Mt Med J; 1967 Nov; 64(11):73-6. PubMed ID: 6062673
[No Abstract] [Full Text] [Related]
5. Amitriptyline + perphenazine, an effective tranquilizer-antidepressant combination.
Shubin H; Mandel S
Psychosomatics; 1967; 8(2):79-81. PubMed ID: 4860194
[No Abstract] [Full Text] [Related]
6. The treatment of anxiety and depression in general practice using an amitriptyline-perphenazine preparation.
Gomez JR; Gomez G
Br J Clin Pract; 1968 Mar; 22(3):105-9. PubMed ID: 5639425
[No Abstract] [Full Text] [Related]
7. Perphenazine-amitriptyline in neurotic underachieving students: a controlled study.
Weise CC; O'Reilly PP; Hesbacher P
Dis Nerv Syst; 1972 May; 33(5):318-25. PubMed ID: 4579412
[No Abstract] [Full Text] [Related]
8. [Use in general and psychosomatic medicine of 2 associations with mixed, anti-depressive and tranquilizing action (amitriptyline + perphenazine)].
Ropert R
Therapeutique; 1970 May; 46(5):527-30. PubMed ID: 5430225
[No Abstract] [Full Text] [Related]
9. Stress-related gastrointestinal dysfunction and combined antidepressant-tranquilizer therapy.
Oren BG
Psychosomatics; 1969; 10(4):258-63. PubMed ID: 4897265
[No Abstract] [Full Text] [Related]
10. [Mutanxion in digestive disorders].
Rumeau
Bord Med; 1970 Nov; 3(11):2813-4. PubMed ID: 5510153
[No Abstract] [Full Text] [Related]
11. The office treatment of mixed anxiety and depression with combination therapy.
Diamond S; Baltes BJ
Psychosomatics; 1969 Nov; 10(6):360-5. PubMed ID: 4907859
[No Abstract] [Full Text] [Related]
12. Treatment of mixed states of anxiety and depression.
Podobnikar IG
Dis Nerv Syst; 1966 Dec; 27(12):811-3. PubMed ID: 5333655
[No Abstract] [Full Text] [Related]
13. A controlled clinical trial of amitriptyline added to perphenazine in the treatment of depressed schizophrenics [proceedings].
Prusoff BA; Williams DH; Weissman MM; Astrachan BM
Psychopharmacol Bull; 1979 Apr; 15(2):80-1. PubMed ID: 373008
[No Abstract] [Full Text] [Related]
14. An evaluation of fluphenazine with nortriptyline in anxiety and depression.
Anderson J; Lambert NG; Pigott PV
Practitioner; 1972 Apr; 208(246):511-7. PubMed ID: 4555519
[No Abstract] [Full Text] [Related]
15. Therapy for mild depressive and anxiety states.
Lytton GJ
Curr Ther Res Clin Exp; 1966 Jul; 8(7):347-50. PubMed ID: 4957168
[No Abstract] [Full Text] [Related]
16. Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study).
McLaughlin BE
Dis Nerv Syst; 1969 Feb; 30(2):Suppl:85-8. PubMed ID: 4886995
[No Abstract] [Full Text] [Related]
17. Etrafon, perphenazine-amitriptyline hydrochloride: a tranquilizer-antidepressant for oral administration.
Curr Ther Res Clin Exp; 1967 Feb; 9(2):89-90. PubMed ID: 4962538
[No Abstract] [Full Text] [Related]
18. Combined amitriptyline-perphenazine (Etrafon) compared with chlordiazepoxide hydrochloride: a double-blind, crossover study.
Martins JK
Curr Ther Res Clin Exp; 1966 Jan; 8(1):17-22. PubMed ID: 4955142
[No Abstract] [Full Text] [Related]
19. The computer analyzes two psychotherapeutic agents in anxiety-depressed states.
Falk MA
Curr Ther Res Clin Exp; 1973 Jul; 15(7):488-99. PubMed ID: 4198312
[No Abstract] [Full Text] [Related]
20. [Therapeutic trial of reactive and neurotic depressions with an amitriptyline-perphenazine combination (long term results in 100 cases)].
Chateau R
Therapeutique; 1973; 49(5):393-5. PubMed ID: 4592773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
